Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H44O3 |
| Molecular Weight | 344.5723 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCCCOCC(O)CO
InChI
InChIKey=OGBUMNBNEWYMNJ-UHFFFAOYSA-N
InChI=1S/C21H44O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24-20-21(23)19-22/h21-23H,2-20H2,1H3
| Molecular Formula | C21H44O3 |
| Molecular Weight | 344.5723 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://en.medicine-cure.com/preparats_1143.htmCurator's Comment: description was created based on several sources, including:
http://lekarstwo.ru/en/preparati/batilolum.html
http://en.medico-online.com/ovr7_batilol.html
Sources: http://en.medicine-cure.com/preparats_1143.htm
Curator's Comment: description was created based on several sources, including:
http://lekarstwo.ru/en/preparati/batilolum.html
http://en.medico-online.com/ovr7_batilol.html
The drug stimulates erythrocytes and leucopoiesis. Applied for the prevention of radiation sickness with X-ray and radiotherapy. For a better intake to take batilol together with a small amount of vegetable oil or butter. Side-effects are neuralgia and allergic reactions.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Study on the chemical constituents of Antipathes dichotoma]. | 2010-09 |
|
| An update on the therapeutic role of alkylglycerols. | 2010-08-05 |
|
| Multiple beneficial health effects of natural alkylglycerols from shark liver oil. | 2010-07-19 |
|
| In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic acid on adipocyte inflammatory mediators. | 2010-04-06 |
|
| [Chemical constituents of a new species of Spongia sponge]. | 2010-04 |
|
| A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton. | 2010-04 |
|
| Antileukemic effects of Didemnum psammatodes (Tunicata: Ascidiacea) constituents. | 2008-11 |
|
| [Clinical experiment of cytokines induced killer cells for treatment of benzene poisoning]. | 2007-09 |
|
| Two new glycosides from the soft coral Sinularia firma. | 2006-12 |
|
| [Chemical constituents from the south China sea gorgonian coral Subergorgia reticulata]. | 2006-06 |
|
| Novel mutual pro-drugs of 2',3'-dideoxyinosine with 3-octadecyloxy-propane-1,2-diol by straightforward enzymatic regioselective synthesis in acetone. | 2005-01 |
|
| A new sphingolipid from the gorgonian Junceella juncea of the Indian Ocean. | 2004-12 |
|
| The Kemp elimination in membrane mimetic reaction media. Probing catalytic properties of cationic vesicles formed from a double-tailed amphiphile and linear long-tailed alcohols or alkyl pyranosides. | 2004-06-21 |
|
| [Isolation and identification of chemical constituents from Acropora pulchra]. | 2001-09 |
|
| Chemical constituents of Pseudopterogorgia species of the Indian ocean. | 2001 |
|
| In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine. | 2000-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://lekarstwo.ru/en/preparati/batilolum.html
0.02 g 2 times a day for prevention and 3 to 4 times a day in the treatment of radiation sickness
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:41:55 GMT 2025
by
admin
on
Mon Mar 31 18:41:55 GMT 2025
|
| Record UNII |
39YR661C4U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID0047799
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL1482516
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
39YR661C4U
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
1454
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
C033433
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
1306190
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000081314
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
208-874-7
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
74001
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
39YR661C4U
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
3681
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
C166663
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
544-62-7
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
34117
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
284200
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
SUB06111MIG
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | |||
|
m2279
Created by
admin on Mon Mar 31 18:41:55 GMT 2025 , Edited by admin on Mon Mar 31 18:41:55 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |